{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T06:53:24Z","timestamp":1746600804182},"reference-count":39,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,3,15]]},"DOI":"10.2169\/internalmedicine.0518-22","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T22:10:12Z","timestamp":1672179012000},"page":"865-869","source":"Crossref","is-referenced-by-count":6,"title":["Colitis with Hypereosinophilia following the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine: A Case Report with a Literature Review"],"prefix":"10.2169","volume":"62","author":[{"given":"Tsuyoshi","family":"Doman","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Sendai Kousei Hospital, Japan"},{"name":"Graduate Medical Education Center, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sendai Kousei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sendai Kousei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Hirasawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sendai Kousei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareyuki","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sendai Kousei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Togo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sendai Kousei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sendai Kousei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. WHO coronavirus (COVID-19) dashboard [Internet]. [cited 2022 Jun 1]. Available from: https:\/\/covid19.who.int\/."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Remmel A. COVID vaccines and safety: what the research says. Nature 590: 538-540, 2021.","DOI":"10.1038\/d41586-021-00290-x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shimabukuro T. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020. Am J Transplant 21: 1332-1337, 2021.","DOI":"10.1111\/ajt.16516"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. McCarthy AJ, Sheahan K. Classification of eosinophilic disorders of the small and large intestine. Virchows Arch 472: 15-28, 2018.","DOI":"10.1007\/s00428-017-2249-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Walker MM, Potter M, Talley NJ. Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus. Lancet Gastroenterol Hepatol 3: 271-280, 2018.","DOI":"10.1016\/S2468-1253(18)30005-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Abdelnabi M, Elmssary M, Sekhon J, Benjanuwattra J. Acute onset of fever, eosinophilia, rash, acute kidney injury, and a positive monospot test in a patient on lamotrigine: DRESS syndrome. Lancet 399: 1902, 2022.","DOI":"10.1016\/S0140-6736(22)00464-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bridges AJ, Marshall JB, Diaz-Arias AA. Acute eosinophilic colitis and hypersensitivity reaction associated with naproxen therapy. Am J Med 89: 526-527, 1990.","DOI":"10.1016\/0002-9343(90)90386-R"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cinotti E, Perrot JL, Bruzziches F, et al. Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination. J Eur Acad Dermatol Venereol 36: e171-e172, 2022.","DOI":"10.1111\/jdv.17806"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Costanzo G, Ledda AG, Ghisu A, Vacca M, Firinu D, Del Giacco S. Eosinophilic granulomatosis with polyangiitis relapse after COVID-19 vaccination: a case report. Vaccines 10: 13, 2021.","DOI":"10.3390\/vaccines10010013"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. de Montjoye L, Marot L, Baeck M. Eosinophilic cellulitis after BNT162b2 mRNA COVID-19 vaccine. J Eur Acad Dermatol Venereol 36: e26-e28, 2022.","DOI":"10.1111\/jdv.17685"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ibrahim H, Alkhatib A, Meysami A. Eosinophilic granulomatosis with polyangiitis diagnosed in an elderly female after the second dose of mRNA vaccine against COVID-19. Cureus 14: e21176, 2022.","DOI":"10.7759\/cureus.21176"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kaikati J, Ghanem A, El Bahtimi R, Helou J, Tomb R. Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccine. J Eur Acad Dermatol Venereol 36: e337-e339, 2022.","DOI":"10.1111\/jdv.17920"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Korekawa A, Nakajima K, Fukushi K, Nakano H, Sawamura D. Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines. J Dermatol 49: 652-655, 2022.","DOI":"10.1111\/1346-8138.16347"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Miqdadi A, Herrag M. Acute eosinophilic pneumonia associated with the anti-COVID-19 vaccine AZD1222. Cureus 13: e18959, 2021.","DOI":"10.7759\/cureus.18959"},{"key":"15","unstructured":"15. Ozturk AB, \u00c7a\u011flayan B, Kapmaz M, et al. Hypersentivity reactions to COVID-19 vaccines: a case of eosinophilic pneumonia following Sinovac\/CoronaVac vaccination. Euro Ann Allergy Clin Immunol. Forthcoming."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ameratunga R, Woon ST, Sheppard MN, et al. First identified case of fatal fulminant necrotizing eosinophilic myocarditis following the initial dose of the Pfizer-BioNTech mRNA COVID-19 vaccine (BNT162b2, Comirnaty): an extremely rare idiosyncratic hypersensitivity reaction. J Clin Immunol 42: 441-447, 2022.","DOI":"10.1007\/s10875-021-01187-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Schroeder JW, Gamba C, Toniato A, et al. A definite case of drug reaction with eosinophilia and systemic symptoms (DRESS) induced by administration of the Pfizer\/BioNTech BNT162b2 vaccine for SARS-CoV2. Clin Dermatol 40: 591-594, 2022.","DOI":"10.1016\/j.clindermatol.2022.02.018"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nappi E, De Santis M, Paoletti G, et al. New onset of eosinophilic granulomatosis with polyangiitis following mRNA-based COVID-19 vaccine. Vaccines 10: 716, 2022.","DOI":"10.3390\/vaccines10050716"},{"key":"19","unstructured":"19. Tiwari A, Karna G, Chakrabarti SS, Panda PK, Kaur U. Hyper-eosinophilic syndrome with myocarditis after inactivated SARS-CoV-2 vaccination - a case study. Curr Drug Saf. Forthcoming."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ikediobi O, Eichenfield DZ, Barrio VR. Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination. Pediatr Dermatol 39: 823-824, 2022.","DOI":"10.1111\/pde.15019"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. O&apos;Connor T, O&apos;Callaghan-Maher M, Ryan P, Gibson G. Drug reaction with eosinophilia and systemic symptoms syndrome following vaccination with the AstraZeneca COVID-19 vaccine. JAAD Case Rep 20: 14-16, 2022.","DOI":"10.1016\/j.jdcr.2021.11.028"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Barrio Piqueras M, Ezponda A, Felgueroso C, et al. Acute eosinophilic pneumonia following mRNA COVID-19 vaccination: a case report. Arch Bronconeumol 58: 53-54, 2022.","DOI":"10.1016\/j.arbres.2021.11.004"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lee JY, Lee JH. mRNA COVID-19 vaccine-associated subserosal eosinophilic gastroenteritis: a case report. J Korean Med Sci 37: e233, 2022.","DOI":"10.3346\/jkms.2022.37.e233"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Morikawa MM, Harada M, Kishimoto E, et al. BNT162b2 coronavirus disease-2019 vaccination accelerated rheumatoid arthritis disease activity in chronic eosinophilic pneumonia: a case report. Medicine 101: e30806, 2022.","DOI":"10.1097\/MD.0000000000030806"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ando M, Satonaga Y, Takaki R, et al. Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty<sup>\u00ae<\/sup>]). Int J Infect Dis 124: 187-189, 2022.","DOI":"10.1016\/j.ijid.2022.09.019"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Rikitake S, Kokubu H, Yamamoto B, Manabe T, Fujimoto N. Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination. Clin Exp Dermatol 47: 2022-2024, 2022.","DOI":"10.1111\/ced.15293"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kimura M, Hashimoto T, Noda E, et al. Fulminant necrotizing eosinophilic myocarditis after COVID-19 vaccination survived with mechanical circulatory support. ESC Heart Fail 9: 2732-2737, 2022.","DOI":"10.1002\/ehf2.13962"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Gill R, Rizvi M, Sadiq MS, Feldman M. Recrudescence of severe polyneuropathy after receiving Pfizer-BioNTech COVID-19 vaccine in a patient with a history of eosinophilic granulomatosis with polyangiitis. BMJ Case Rep 15: e245749, 2022.","DOI":"10.1136\/bcr-2021-245749"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. May J, Draper A, Aul R. Eosinophilic pneumonia and COVID-19 vaccination. QJM 115: 251-252, 2022.","DOI":"10.1093\/qjmed\/hcac041"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Pornsuriyasak P, Suwatanapongched T, Klaewsongkram J, Buranapraditkun S, Rotjanapan P. Acute respiratory failure secondary to eosinophilic pneumonia following influenza vaccination in an elderly man with chronic obstructive pulmonary disease. Int J Infect Dis 26: 14-16, 2014.","DOI":"10.1016\/j.ijid.2014.04.019"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kikuchi R, Iwai Y, Watanabe Y, Nakamura H, Aoshiba K. Acute respiratory failure due to eosinophilic pneumonia following pneumococcal vaccination. Hum Vaccin Immunother 15: 2914-2916, 2019.","DOI":"10.1080\/21645515.2019.1631134"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Safran T, Masckauchan M, Maj J, Green L. Wells syndrome secondary to influenza vaccination: a case report and review of the literature. Hum Vaccin Immunother 14: 958-960, 2018.","DOI":"10.1080\/21645515.2017.1417714"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Solak B, Dikicier BS, Kara RO, Erdem T. DRESS syndrome potentially induced by allopurinol and triggered by influenza vaccine. BMJ Case Rep 2016: bcr2016214563, 2016.","DOI":"10.1136\/bcr-2016-214563"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Terhune TD, Deth RC. Aluminum adjuvant-containing vaccines in the context of the hygiene hypothesis: a risk factor for eosinophilia and allergy in a genetically susceptible subpopulation? Int J Environ Res Public Health 15: 901, 2018.","DOI":"10.3390\/ijerph15050901"},{"key":"35","unstructured":"35. Barbaud A, Garvey LH, Arcolaci A, et al. Allergies and COVID-19 vaccines: an ENDA\/EAACI position paper. Allergy 77: 2292-2312, 2022."},{"key":"36","unstructured":"36. Nair AP, Soliman A, Al Masalamani MA, et al. Clinical outcome of eosinophilia in patients with COVID-19: a controlled study. Acta Biomed 91: e2020165, 2020."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Rodrigo-Mu\u00f1oz JM, Sastre B, Ca\u00f1as JA, Gil-Mart\u00ednez M, Redondo N, Del Pozo V. Eosinophil response against classical and emerging respiratory viruses: COVID-19. J Investig Allergol Clin Immunol 31: 94-107, 2021.","DOI":"10.18176\/jiaci.0624"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kadali RAK, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Int J Infect Dis 106: 376-381, 2021.","DOI":"10.1016\/j.ijid.2021.04.047"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Costa e Silva M, S\u00e1 Marques M, Jo\u00e3o D, Campainha S. Eosinophilic pneumonia associated to SARS-CoV-2 vaccine. Arch Bronconeumol 58: 51-52, 2022.","DOI":"10.1016\/j.arbres.2021.10.008"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/6\/62_0518-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:43Z","timestamp":1715315503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/6\/62_0518-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0518-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"article-number":"0518-22"}}